Faculty and Staff
|
Pan-Chyr Yang
Field of study：Pharmacology
My job：Internal Medicine Physician (NTUH)
Stage shifts in national lung adenocarcinoma and the impact of opportunistic self-initiated LDCT screening in Taiwan: a nationwide population-based cohort study.
(2026-06) Wu, Jia-Jun ; CHUN-JU CHIANG ; Chen, Chia-Hung ; Tseng, Jeng-Sen ; Feng, Po-Hao ; Yang, Ya-Wen ; Zheng, Zhe-Rong ; Chu, Cheng-Hsiang ; Yang, Chih-Jen ; Chong, Inn-Wen ; Tu, Chih-Yen ; WEN-CHUNG LEE ; Hsia, Jiun-Yi ; Chen, Kun-Chieh ; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang, Gee-Chen
Author Correction: Innovative approaches for lung cancer screening and interception.
(2026-05) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapy.
(2026-03-30) Tseng, S-Ja ; Kempson, Ivan M ; Ho, Yi-Cheng ; PAN-CHYR YANG ; Liao, Zi-Xian
Innovative approaches for lung cancer screening and interception.
(2026-02-23) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
First-line risk stratification with machine learning models facilitates rapid triage for non-ST-elevation myocardial infarction.
(2026-02) Luo, Wei-Jia ; Liou, Yih-Mei ; Hsiao, Cheng-Han ; CHI-SHENG HUNG ; HENG-YU PAN ; PAN-CHYR YANG ; CHIEN-HUA HUANG ; KANG-YI SU
(2026-06) Wu, Jia-Jun ; CHUN-JU CHIANG ; Chen, Chia-Hung ; Tseng, Jeng-Sen ; Feng, Po-Hao ; Yang, Ya-Wen ; Zheng, Zhe-Rong ; Chu, Cheng-Hsiang ; Yang, Chih-Jen ; Chong, Inn-Wen ; Tu, Chih-Yen ; WEN-CHUNG LEE ; Hsia, Jiun-Yi ; Chen, Kun-Chieh ; PAN-CHYR YANG ; SUNG-LIANG YU ; Chang, Gee-Chen
Author Correction: Innovative approaches for lung cancer screening and interception.
(2026-05) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
pH-responsive virus-drug conjugates for targeted PD-L1 silencing and enhanced cancer immunotherapy.
(2026-03-30) Tseng, S-Ja ; Kempson, Ivan M ; Ho, Yi-Cheng ; PAN-CHYR YANG ; Liao, Zi-Xian
Innovative approaches for lung cancer screening and interception.
(2026-02-23) Zhang, Jianjun ; Park, Matthew D ; Pandya, Tej ; Shum, Elaine ; Wu, Jia ; Heeke, Simon ; Salehi-Rad, Ramin ; Marron, Thomas U ; Wei, Zhubo ; Li, Hui ; Blum, Torsten G ; Heymach, John V ; Dubinett, Steven M ; PAN-CHYR YANG ; Swanton, Charles ; Merad, Miriam
First-line risk stratification with machine learning models facilitates rapid triage for non-ST-elevation myocardial infarction.
(2026-02) Luo, Wei-Jia ; Liou, Yih-Mei ; Hsiao, Cheng-Han ; CHI-SHENG HUNG ; HENG-YU PAN ; PAN-CHYR YANG ; CHIEN-HUA HUANG ; KANG-YI SU
Develop an Innovative Drug Discovery Platform Targeting Kras Mutation-Driven Resistance in Lung Adenocarcinoma = 開發設計新穎藥物平台，針對KRAS突變產生抗藥性之肺腺癌
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (III) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (III)
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (II) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (II)
(2024-08-01～) PAN-CHYR YANG
Gps-Based High-Throughput Screening of Drugs Modulating Tumor Microenvironment - Pd-L1 as Targets for Cancer Immunotherapy (III) = 利用高通量蛋白穩定度藥物篩選技術(GPS)對腫瘤微環境中蛋白調控進行新藥開發 - 以PD-L1免疫治療為例 (III)
(2024-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (I) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (I)
(2023-08-01～) PAN-CHYR YANG
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (III) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (III)
(2025-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (II) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (II)
(2024-08-01～) PAN-CHYR YANG
Gps-Based High-Throughput Screening of Drugs Modulating Tumor Microenvironment - Pd-L1 as Targets for Cancer Immunotherapy (III) = 利用高通量蛋白穩定度藥物篩選技術(GPS)對腫瘤微環境中蛋白調控進行新藥開發 - 以PD-L1免疫治療為例 (III)
(2024-08-01～) PAN-CHYR YANG
Development of Novel Phagocytosis Therapeutic Antibody for Lung Cancer (I) = 開發促腫瘤細胞吞噬的新穎性肺癌治療抗體 (I)
(2023-08-01～) PAN-CHYR YANG